Halo Pharma is a full-service contract manufacturing and development organization that partners with large pharmaceutical, biotech, and generic pharmaceutical companies. Halo has two plants totaling 500,000 ft2, over 500 employees, FDA, EMEA, DEA, and Health Canada approvals for both plants as well as particular expertise in controlled and modified-release products, topicals, oral liquids and controlled substances.
Halo Pharmaceutical, Inc
Whippany, NJ
tel. 973.428.4087
INTERPHEX Booth #1462
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.